Mainstream

Heron Therapeutics Gaap Eps Of $0.02 Beats By $0.05, Revenue Of $40.78m Beats By $3.41m

Heron Therapeutics GAAP EPS of $0.02 beats by $0.05, revenue of $40.78M beats by $3.41M

Heron Therapeutics GAAP EPS of $0.02 beats by $0.05, revenue of $40.78M beats by $3.41M

Post ContenthrtxRead More

You might also be interested in reading Canary’s amended S-1 has analysts more confident a Litecoin ETF is next.

February 27, 2025
In Mainstream